Significance and possibilities of cytostatic treatment of malignant tumors: testing the effects of cytostatics
Král, V.; Hajdúch, M.; Neoral, C.; Klein, J.; Mihál, V.; Orel, M.; Aujeský, R.; Vyslouzil, K.; Cwiertka, K.; Kolek, V.; Nosková, V.
Rozhledy V Chirurgii Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 79(3): 134-138
2000
ISSN/ISBN: 0035-9351 PMID: 10838948 Document Number: 524415
The authors present an account on the initiation of a study concerned with the administration of cytostatics according to the sensitivity of the tumour cells. To assess the sensitivity the MTT test was used. The method is described in the paper. Four groups of tumours were examined by the MTT test: breast cancer, carcinoma of the colon and rectum, of the lungs and oesophagus + stomach. Six cytostatics were tested: 5-fluorouracil, cisplatinum, daunorubucin, paclitaxel, vincristine, and vepeside. Evaluation of the sensitivity of different tumours was based on the median of TCS50. The results of the MTT test were not used so far in the therapeutic protocol in all patients where the examination was made, as in solid tumours, contrary to haemo-blastomas, usually common empirically tested protocols are used. The authors reflect whether individually administered cytostatics according to the MTT test can improve the prognosis of patients with malignant diseases. They assume that long-term follow-up of the patients may provide favourable results in particular because more and more effective cytostatics are becoming available.